A Phase ⅠClinical Trial of Recombinant Hepatitis B Vaccine (Hansenula Polymorpha, 10μg) With an Open-labelled Design in Adults and a Randomized, Double-blinded, Positive Controlled Design in Children and Neonates
Latest Information Update: 02 Aug 2021
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- Sponsors Sinovac Biotech
Most Recent Events
- 26 Jul 2021 Status changed from recruiting to completed.
- 06 Sep 2019 New trial record